ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,631Medicare Part D Prescriptions Filled, Including Refills

Rank: 19 out of 1844

$1.36M Total Retail Price of All Prescriptions

Rank: 20 out of 1844

689 Patients Receiving at Least One Drug in Part D
61%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 689 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

30% of this provider’s 689 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 13,697 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
HYDROCODONE-ACETAMINOPHEN 1,294 506 S3 1 2
LEVOTHYROXINE SODIUM 759 546 2 1
METOPROLOL TARTRATE 700 478 3 11
FUROSEMIDE 685 514 4 7
SIMVASTATIN 633 414 5 3
OMEPRAZOLE 616 319 6 5
CITALOPRAM HBR 568 352 7 19
LISINOPRIL 474 331 8 4
RANITIDINE HCL 473 256 9 38
METFORMIN HCL 471 324 10 8
NAPROXEN 357 175 11 87
POTASSIUM CHLORIDE 302 253 12 16
TRAMADOL HCL 299 181 13 18
WARFARIN SODIUM 284 207 14 13
CYCLOBENZAPRINE HCL 265 49 R 15 53
CEPHALEXIN 255 130 16 56
FENTANYL 251 75 S2 17 66
GABAPENTIN 246 155 18 15
LANTUS 228 177 19 42
OXYCODONE HCL-ACETAMINOPHEN 223 51 S2 20 83
TAMSULOSIN HCL 218 173 21 27
AMLODIPINE BESYLATE 208 186 22 6
SERTRALINE HCL 192 69 23 21
ZOLPIDEM TARTRATE 192 107 23 23
ALLOPURINOL 189 148 25 29
CLOPIDOGREL 184 150 26 34
NYSTATIN 176 121 27 85
PANTOPRAZOLE SODIUM 176 128 27 32
GLIPIZIDE 175 112 29 70
CYMBALTA 175 79 29 36
FLUOXETINE HCL 165 104 31 41
FAMOTIDINE 161 90 32 63
IBUPROFEN 161 51 32 89
DONEPEZIL HCL 152 148 34 26
METOPROLOL SUCCINATE 149 107 35 14
TRIAMTERENE-HYDROCHLOROTHIAZID 142 103 36 161
OXYCONTIN 140 0 S2 37 144
ISOSORBIDE MONONITRATE ER 140 114 37 59
ABILIFY 139 35 39 150
CARVEDILOL 138 110 40 22
ESCITALOPRAM OXALATE 133 96 41 52
SPIRONOLACTONE 133 103 41 60
ALENDRONATE SODIUM 125 88 43 25
PROMETHAZINE HCL 124 45 R 44 88
NAMENDA 124 121 44 33
KLOR-CON M20 123 104 46 54
NEXIUM 122 34 47 31
PROAIR HFA 121 33 48 45
AMOXICILLIN 119 58 49 101
CELEBREX 109 89 50 91
ATORVASTATIN CALCIUM 108 73 51 12
QUETIAPINE FUMARATE 107 94 52 82
DIGOXIN 105 78 53 67
HYDROCHLOROTHIAZIDE 103 74 54 9
OXYBUTYNIN CHLORIDE ER 101 73 55 126
PLAVIX 101 74 55 61
AMITRIPTYLINE HCL 101 56 R 55 72
LEVOFLOXACIN 100 72 58 78
KLOR-CON M10 97 83 59 149
NOVOLOG 94 84 60 84
CIPROFLOXACIN HCL 93 53 61 62
CARBIDOPA-LEVODOPA 90 82 62 86
AZITHROMYCIN 88 43 63 37
CLOTRIMAZOLE-BETAMETHASONE 88 59 63 202
TRAZODONE HCL 86 0 65 43
COMBIVENT 85 35 66 131
MECLIZINE HCL 84 40 67 142
ADVAIR DISKUS 79 49 68 51
LISINOPRIL-HYDROCHLOROTHIAZIDE 79 45 68 20
SULFAMETHOXAZOLE-TRIMETHOPRIM 79 39 68 73
LANTUS SOLOSTAR 79 23 68 97
OLANZAPINE 78 51 72 117
TRIAMTERENE-HCTZ 78 54 72 48
PREDNISONE 76 62 74 40
MUPIROCIN 76 47 74 189
ACETAMINOPHEN-CODEINE 76 36 S3 74 143
PAROXETINE HCL 75 37 77 68
VENLAFAXINE HCL ER 74 0 78 93
ALPRAZOLAM 74 0 78 124
OXYCODONE-ACETAMINOPHEN 74 27 S2 78 94
HUMALOG 73 32 81 114
ATENOLOL 72 51 82 17
RISPERIDONE 72 37 82 65
PEN NEEDLE 72 36 82 135
EVISTA 71 63 85 95
DIOVAN HCT 71 65 85 96
MELOXICAM 70 42 87 28
INSULIN SYRINGE 68 49 88 111
TIZANIDINE HCL 66 48 89 141
VENTOLIN HFA 64 46 90 145
SPIRIVA 64 35 90 57
POLYETHYLENE GLYCOL 3350 63 54 92 39
ALBUTEROL SULFATE 63 53 92 115
VERAPAMIL ER 60 45 94 98
OXYBUTYNIN CHLORIDE 59 49 95 103
GLIPIZIDE ER 59 40 95 79
FLUCONAZOLE 58 17 97 187
CRESTOR 57 41 98 30
NITROFURANTOIN 56 54 99 253
METFORMIN HCL ER 56 47 99 46
METHOCARBAMOL 55 30 R 101 241
METHYLPREDNISOLONE 55 23 101 125
PRAVASTATIN SODIUM 54 40 103 10
SYNTHROID 54 50 103 55
ROPINIROLE HCL 54 29 103 76
METRONIDAZOLE 53 45 106 311
METOCLOPRAMIDE HCL 51 40 107 148
PERPHENAZINE-AMITRIPTYLINE 51 22 R 107 451
ACTOS 50 26 109 130
LYRICA 50 26 109 92
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 7, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.